HUE057365T2 - Triciklusos benzoxaborol vegyületek és felhasználásuk - Google Patents

Triciklusos benzoxaborol vegyületek és felhasználásuk

Info

Publication number
HUE057365T2
HUE057365T2 HUE14834292A HUE14834292A HUE057365T2 HU E057365 T2 HUE057365 T2 HU E057365T2 HU E14834292 A HUE14834292 A HU E14834292A HU E14834292 A HUE14834292 A HU E14834292A HU E057365 T2 HUE057365 T2 HU E057365T2
Authority
HU
Hungary
Prior art keywords
benzoxaborol compounds
tricyclic benzoxaborol
tricyclic
compounds
benzoxaborol
Prior art date
Application number
HUE14834292A
Other languages
English (en)
Hungarian (hu)
Inventor
M R K Alley (Dickon)
Vincent S Hernandez
Jacob J Plattner
Xianfeng Li
David Barros-Aguirre
Ilaria Giordano
Original Assignee
Glaxosmithkline Ip No 2 Ltd
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip No 2 Ltd, Anacor Pharmaceuticals Inc filed Critical Glaxosmithkline Ip No 2 Ltd
Publication of HUE057365T2 publication Critical patent/HUE057365T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/04Esters of boric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HUE14834292A 2013-08-09 2014-08-08 Triciklusos benzoxaborol vegyületek és felhasználásuk HUE057365T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361864496P 2013-08-09 2013-08-09
US201361918976P 2013-12-20 2013-12-20

Publications (1)

Publication Number Publication Date
HUE057365T2 true HUE057365T2 (hu) 2022-05-28

Family

ID=52462052

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14834292A HUE057365T2 (hu) 2013-08-09 2014-08-08 Triciklusos benzoxaborol vegyületek és felhasználásuk

Country Status (35)

Country Link
US (5) US20160251380A1 (https=)
EP (2) EP4029870A1 (https=)
JP (2) JP6499175B2 (https=)
KR (1) KR102093783B1 (https=)
CN (2) CN105492388B (https=)
AP (1) AP2016009046A0 (https=)
AU (2) AU2014305792C1 (https=)
BR (1) BR112016002651B1 (https=)
CA (1) CA2919888C (https=)
CL (1) CL2016000313A1 (https=)
CR (1) CR20160064A (https=)
CY (1) CY1125030T1 (https=)
DK (1) DK3030519T3 (https=)
DO (1) DOP2016000045A (https=)
EA (1) EA032844B1 (https=)
ES (1) ES2905413T3 (https=)
HR (1) HRP20220384T1 (https=)
HU (1) HUE057365T2 (https=)
IL (1) IL243874B (https=)
LT (1) LT3030519T (https=)
MX (1) MX375556B (https=)
MY (1) MY175823A (https=)
NZ (1) NZ716350A (https=)
PE (1) PE20160752A1 (https=)
PH (1) PH12016500234B1 (https=)
PL (1) PL3030519T3 (https=)
PT (1) PT3030519T (https=)
RS (1) RS62887B1 (https=)
SA (1) SA516370551B1 (https=)
SG (2) SG11201600787PA (https=)
SI (1) SI3030519T1 (https=)
SM (1) SMT202200113T1 (https=)
UA (1) UA116908C2 (https=)
WO (1) WO2015021396A2 (https=)
ZA (1) ZA201600792B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR094961A1 (es) * 2013-03-15 2015-09-09 Lilly Co Eli 1-hidroxi-benzooxaboroles como agentes antiparasitarios
KR101636431B1 (ko) 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
US20160251380A1 (en) 2013-08-09 2016-09-01 Glaxosmithkline Intellectual Property (No.2) Limited Tricyclic benzoxaborole compounds and uses thereof
EP3164404B1 (en) 2014-07-01 2019-04-03 Daiichi Sankyo Company, Limited Tricyclic benzoxaboroles as antibacterial agents
MA41494B1 (fr) * 2015-02-12 2020-10-28 Glaxosmithkline Ip No 2 Ltd Composés benzoxaborole substitués en position 4 et utilisations associées
CR20180560A (es) 2016-05-12 2019-01-25 Anacor Pharmaceuticals Inc Ésteres de oxaboral y sus usos
CN109387594B (zh) * 2017-08-08 2021-01-19 武汉武药科技有限公司 一种分离和分析贝达喹啉光学异构体的方法
PL3737685T3 (pl) * 2018-01-09 2023-10-02 Halcyon Labs Private Limited Sposób wytwarzania kryzaborolu i jego związków pośrednich
WO2021257466A1 (en) * 2020-06-15 2021-12-23 The Global Alliance For Tb Drug Development, Inc. Combination antibacterial composition and method for antibacterial therapy
CN111606850B (zh) * 2020-07-07 2023-07-25 安徽贝克生物制药有限公司 贝达喹啉及其中间体的制备方法
US11793808B2 (en) 2021-02-22 2023-10-24 Mannkind Corp. Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
EP4384527A4 (en) * 2022-06-23 2025-09-03 Micurx Pharmaceuticals Inc PRODRUGS OF BORON COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
CA3239096A1 (en) * 2022-06-23 2023-12-28 Shanghai Micurx Pharmaceutical Co., Ltd. Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same
WO2024208907A1 (en) 2023-04-05 2024-10-10 Glaxosmithkline Intellectual Property (No. 2) Limited Synthesis of 3-(aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3h)-ol
CN117379430A (zh) * 2023-10-11 2024-01-12 深圳市第三人民医院(深圳市肝病研究所) 一种地拉韦啶的用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0947498B1 (en) 1996-12-02 2004-09-15 Chisso Corporation Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same
US7446236B2 (en) 2002-12-02 2008-11-04 Solvias Ag Catalytic hydrogenation of carbon-heteroatom double bonds
EP2343304B1 (en) * 2005-02-16 2015-06-10 Anacor Pharmaceuticals, Inc. Biocidal boronophthalide compounds
EP1856113B1 (en) 2005-03-08 2016-01-06 Agency for Science, Technology and Research Chiral bisoxazoline catalysts
CN101505603A (zh) * 2005-12-30 2009-08-12 安纳考尔医药公司 含硼的小分子
KR20080110984A (ko) * 2005-12-30 2008-12-22 아나코르 파마슈티칼스 인코포레이티드 보론함유 소분자
KR100848491B1 (ko) 2007-01-16 2008-07-28 영진약품공업주식회사 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
WO2010080558A1 (en) 2008-12-17 2010-07-15 Anacor Pharmaceuticals, Inc. Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
ES2710105T3 (es) * 2010-04-07 2019-04-23 Glaxosmithkline Llc Proceso para preparar benzoxaboroles
SI3251678T1 (sl) * 2010-09-07 2022-01-31 Anacor Pharmaceuticals, Inc. Derivati benzoksaborola za zdravljenje bakterijskih okužb
JP6031122B2 (ja) * 2011-12-22 2016-11-24 ミクウルク ファーマシューティカルズ,インコーポレイテッド 抗微生物療法のための三環式ホウ素化合物
KR101636431B1 (ko) 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
US20160251380A1 (en) 2013-08-09 2016-09-01 Glaxosmithkline Intellectual Property (No.2) Limited Tricyclic benzoxaborole compounds and uses thereof
MA41494B1 (fr) * 2015-02-12 2020-10-28 Glaxosmithkline Ip No 2 Ltd Composés benzoxaborole substitués en position 4 et utilisations associées

Also Published As

Publication number Publication date
US20180044355A1 (en) 2018-02-15
CN105492388B (zh) 2018-12-21
LT3030519T (lt) 2022-04-11
SMT202200113T1 (it) 2022-05-12
CL2016000313A1 (es) 2016-09-23
US10308668B2 (en) 2019-06-04
CN110003253A (zh) 2019-07-12
SI3030519T1 (sl) 2022-04-29
US10526352B2 (en) 2020-01-07
JP2016527321A (ja) 2016-09-08
EP4029870A1 (en) 2022-07-20
HK1219939A1 (zh) 2017-04-21
AU2014305792A1 (en) 2016-03-10
AP2016009046A0 (en) 2016-02-29
JP2019123727A (ja) 2019-07-25
PH12016500234A1 (en) 2016-05-16
CN105492388A (zh) 2016-04-13
AU2014305792B2 (en) 2017-05-04
DK3030519T3 (da) 2022-01-31
IL243874A0 (en) 2016-04-21
MY175823A (en) 2020-07-10
SG10201914073PA (en) 2020-03-30
CN110003253B (zh) 2022-03-18
AU2014305792C1 (en) 2018-07-05
KR102093783B1 (ko) 2020-03-26
HRP20220384T1 (hr) 2022-07-22
BR112016002651A2 (pt) 2017-08-01
SG11201600787PA (en) 2016-03-30
CY1125030T1 (el) 2023-03-24
EA032844B1 (ru) 2019-07-31
US20190241586A1 (en) 2019-08-08
WO2015021396A3 (en) 2015-10-29
NZ716350A (en) 2022-12-23
US20210053999A1 (en) 2021-02-25
MX2016001732A (es) 2016-05-18
CA2919888C (en) 2022-10-18
ZA201600792B (en) 2022-05-25
CA2919888A1 (en) 2015-02-12
CR20160064A (es) 2016-06-01
PL3030519T3 (pl) 2022-05-23
WO2015021396A9 (en) 2016-02-11
IL243874B (en) 2018-11-29
JP6764970B2 (ja) 2020-10-07
ES2905413T3 (es) 2022-04-08
PH12016500234B1 (en) 2019-01-30
RS62887B1 (sr) 2022-03-31
BR112016002651B1 (pt) 2022-11-29
DOP2016000045A (es) 2016-04-29
MX375556B (es) 2025-03-06
US20200095266A1 (en) 2020-03-26
AU2017210567B2 (en) 2019-08-01
EP3030519A4 (en) 2017-03-08
WO2015021396A2 (en) 2015-02-12
US10858376B2 (en) 2020-12-08
SA516370551B1 (ar) 2017-10-31
PT3030519T (pt) 2022-01-27
EP3030519A2 (en) 2016-06-15
AU2017210567A1 (en) 2017-08-24
UA116908C2 (uk) 2018-05-25
US20160251380A1 (en) 2016-09-01
EA201690135A1 (ru) 2016-07-29
JP6499175B2 (ja) 2019-04-10
EP3030519B1 (en) 2022-01-05
PE20160752A1 (es) 2016-08-17
KR20160038901A (ko) 2016-04-07

Similar Documents

Publication Publication Date Title
HUE057365T2 (hu) Triciklusos benzoxaborol vegyületek és felhasználásuk
HUE057734T2 (hu) Heterociklusos vegyületek és alkalmazásuk
DK3381917T3 (da) Imidazopyridinforbindelser og anvendelser deraf
HUE046559T2 (hu) Policiklusos karbamoilpiridon vegyületek és gyógyszerészeti alkalmazásuk
HUE053410T2 (hu) Alkalmazási eljárás és alkalmazási berendezés
HRP20181392T1 (hr) Heterociklični spojevi i njihova uporaba
HUE033528T2 (hu) Szubsztituált xantinok és eljárások azok alkalmazására
DK3052140T3 (da) Ikke-selvklæbende coatingmaterialer
DK3063144T3 (da) Antiparasitære og pesticid-isoxazolinforbindelser
DK3038654T3 (da) Ny anvendelse
DK3077467T3 (da) Sikkativsammensætning og anvendelse deraf
DK3030549T3 (da) Pyridazinonforbindelser og anvendelser deraf
DK2991633T3 (da) Bakteriofagterapi
HUE053539T2 (hu) TiB2 rétegek és elõállításuk
EP3012307A4 (en) MIXED REFRIGERANT
DE102014221388B8 (de) Ladezustands-Berechungsvorrichtung
HUE050917T2 (hu) Hidrokortizon-tartalmú készítmény
EP3047192A4 (en) LOCKABLE LOCATED CONNECTOR
FR3007291B1 (fr) Composition cicatrisante et utlisation
EP2948430A4 (en) phenylacetylenes
TH148825B (th) สารประกอบเตตระโซลิโนนและการใช้ของสิ่งนั้น
GB201313605D0 (en) Novel compounds and their use
UA27113S (uk) Обручка з написом
TH1501003524A (th) เม็ดสี
UA30187S (uk) Ампула